▲ Up
 
01:59 06-05-2016
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanMongoliaWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
18:16 India's Reliance Power bags $1.3 bn project in Bangladesh16:39 Centerra Gold Inc. not confident discussions with Kyrgyz government to result in mutually acceptable solution for Kumtor project16:26 Centerra's proxy advisory firms recommend shareholders vote for all nominees for Director to Board16:23 President of Afghanistan to visit Dushanbe16:15 Kumtor Gold Company explains leave of its top managers with planned vacations16:11 Centerra Gold Inc. confirms temporary suspension of trading in its securities16:01 Ambassador of Tajikistan presents credentials to President of Armenia15:54 Tajikistan, Turkey review cooperation in trade, law enforcement15:49 Tajikistan, China discuss bilateral ties15:42 Almaty court imprisons man for unsanctioned rally in protest against land code15:26 Kazakhstan seeks close political ties with Poland – President15:15 Kazakhstan achieves 3-fold reduction of infant mortality rate since 199114:59 Government orders establishment of lab to analyze quality of Kara-Keche coal delivered to Bishkek CHPP14:53 Partnership in international child adoption with Kyrgyzstan among priorities for U.S. - Ambassador14:47 Kyrgyz government to pay over $200 to WWII, prisoners of concentration camps each14:37 Kazakhstan not to hold Victory Day Parade14:35 Landslide in Uzbekistan kills 514:29 Kyrgyzstan, Kuwait vow to bolster ties in youth, sports14:12 Kyrgyzstani among detained Central Asians in Moscow over terror attack plot14:01 Uzbekistan increases fruit exports to Russia
Astana
+15° C
Ashgabat
+34° C
Bishkek
+20° C
Dushanbe
+25° C
Tashkent
+26° C
Ulaanbaatar
+1° C
exchange rates
 
78.21
68.26
10.55
1.06
381.79
332.51
51.15
5.01
6.85
6.26
1.01
0.12
3286.53
2888.39
446.81
42.81
4.02
3.50
0.54
0.05

© AKIpress News Agency - 2001-2016. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75